Product Information
CARBAMAZEPINE ER 400 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.6070 per EA under NDC 62135093060. Its NADAC has been published 52 times since Jul 2, 2025.
Strength
400 mg/1
Manufacturer
Chartwell RX LLCNDC
62135093060
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215591On Market Since
3/31/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE ER 400 MG TABLET has been published 52 times since Jul 2, 2025, and over the history we have for it it has declined 11.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6070 per EA |
|---|---|
| All-time high | $0.7270 (Dec 10, 2025) |
| All-time low | $0.5655 (Apr 22, 2026) |
| 52-week high | $0.7270 |
| 52-week low | $0.5655 |
| Median price | $0.6617 |
| Average price | $0.6509 |
| Largest weekly change | -7.9% (Feb 18, 2026) |
| Weeks tracked | 52 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Carbamazepine ER market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 400 MG TABLET, manufactured by Chartwell RX LLC, is $0.6070 per EA (NDC 62135093060), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has declined 11.3%. It has been tracked across 52 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 400 MG TABLET?
Since Jul 2, 2025, the NADAC for CARBAMAZEPINE ER 400 MG TABLET has ranged from a low of $0.5655 (Apr 22, 2026) to a high of $0.7270 (Dec 10, 2025), with a median of $0.6617 per EA.
Are there cheaper alternatives to CARBAMAZEPINE ER 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBAMAZEPINE ER 400 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CARBAMAZEPINE ER 400 MG TABLET?
CARBAMAZEPINE ER 400 MG TABLET (NDC 62135093060) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification